Domestic price of eltrombopag

Eltrombopag (Eltrombopag) is a drug used to treat thrombocytopenia. It has been launched in China and is included in medical insurance. Due to differences in local medical insurance policies, there are certain differences in the medical insurance reimbursement prices of Eltrombopag. Under normal circumstances, the medical insurance price of Eltrombopag will be lower than the self-pay price, but the specific reimbursement ratio and cost need to be determined according to the medical insurance regulations of each region and the patient's personal situation.

in the country, the original drug of Eltrombopag is usually around more than 1,000 yuan. Original drugs are usually provided by pharmaceutical companies, and their quality and ingredients are relatively stable. Medical insurance policies in some areas will cover the cost of Eltrombopag, but patients may still have to bear a certain proportion of out-of-pocket expenses. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau.

In addition, there are also some generic drugs of Eltrombopag abroad, which are usually cheaper than the original drugs. Generic versions include drugs produced in India, Bangladesh, Laos and other places, and the price of these generic drugs is usually around a few hundred yuan. Although these generic drugs are more affordable, they have basically the same ingredients as the original drugs, and there is usually no significant difference in efficacy.

For patients, when choosing to purchase Eltrombopag, in addition to considering the price, they also need to choose the appropriate drug based on the doctor's advice and personal condition. Patients should also understand the relevant medical insurance policies in their region in order to reasonably arrange their drug purchase budget. If the cost of eltrombopag is not fully covered in the area, the patient can pay part of it through medical insurance, and the remaining cost must be paid out of pocket.

To sum up, Eltrombopag has been launched in China and is included in medical insurance. Patients can choose the original drug or generic drug according to the specific situation, and purchase the drug in accordance with the medical insurance policy. Since medical insurance policies vary greatly from place to place, it is recommended that patients consult the local hospital pharmacy or medical insurance bureau to obtain more accurate drug prices and reimbursement status.